MONECO Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.57M | Buy |
13,015
+526
| +4% | +$60.7K | 0.12% | 162 |
|
|
2025
Q4 | $1.31M | Buy |
12,489
+186
| +2% | +$17.5K | 0.1% | 181 |
|
|
2025
Q3 | $1.03M | Buy |
12,303
+99
| +0.8% | +$8.15K | 0.09% | 200 |
|
|
2025
Q2 | $966K | Buy |
12,204
+89
| +0.7% | +$7.07K | 0.09% | 197 |
|
|
2025
Q1 | $1.09M | Sell |
12,115
-1,332
| -10% | -$124K | 0.11% | 168 |
|
|
2024
Q4 | $1.34M | Buy |
13,447
+2,596
| +24% | +$268K | 0.14% | 148 |
|
|
2024
Q3 | $1.23M | Sell |
10,851
-373
| -3% | -$44.3K | 0.15% | 137 |
|
|
2024
Q2 | $1.39M | Sell |
11,224
-372
| -3% | -$47.9K | 0.2% | 118 |
|
|
2024
Q1 | $1.53M | Buy |
11,596
+777
| +7% | +$95.8K | 0.24% | 110 |
|
|
2023
Q4 | $1.18M | Buy |
10,819
+243
| +2% | +$25.2K | 0.22% | 119 |
|
|
2023
Q3 | $1.09M | Buy |
10,576
+543
| +5% | +$58.5K | 0.3% | 84 |
|
|
2023
Q2 | $1.16M | Sell |
10,033
-104
| -1% | -$11.8K | 0.32% | 77 |
|
|
2023
Q1 | $1.08M | Buy |
10,137
+3,363
| +50% | +$363K | 0.32% | 82 |
|
|
2022
Q4 | $752K | Sell |
6,774
-68
| -1% | -$6.95K | 0.27% | 93 |
|
|
2022
Q3 | $589K | Sell |
6,842
-100
| -1% | -$8.93K | 0.24% | 104 |
|
|
2022
Q2 | $633K | Buy |
6,942
+409
| +6% | +$36.3K | 0.25% | 97 |
|
|
2022
Q1 | $536K | Buy |
6,533
+320
| +5% | +$25.2K | 0.2% | 122 |
|
|
2021
Q4 | $491K | Buy |
6,213
+187
| +3% | +$14.9K | 0.18% | 127 |
|
|
2021
Q3 | $453K | Buy |
6,026
+1,291
| +27% | +$98.2K | 0.18% | 126 |
|
|
2021
Q2 | $368K | Sell |
4,735
-215
| -4% | -$16K | 0.17% | 134 |
|
|
2021
Q1 | $364K | Buy |
4,950
+11
| +0.2% | +$811 | 0.18% | 131 |
|
|
2020
Q4 | $388K | Buy |
4,939
+762
| +18% | +$58.3K | 0.21% | 109 |
|
|
2020
Q3 | $331K | Buy |
4,177
+243
| +6% | +$19K | 0.21% | 105 |
|
|
2020
Q2 | $290K | Buy |
3,934
+175
| +5% | +$13.2K | 0.23% | 103 |
|
|
2020
Q1 | $276K | Sell |
3,759
-110
| -3% | -$8.64K | 0.28% | 89 |
|
|
2019
Q4 | $336K | Buy |
3,869
+229
| +6% | +$18.8K | 0.24% | 94 |
|
|
2019
Q3 | $292K | Buy |
3,640
+830
| +30% | +$66.5K | 0.23% | 93 |
|
|
2019
Q2 | $225K | Sell |
2,810
-246
| -8% | -$18.8K | 0.18% | 117 |
|
|
2019
Q1 | $243K | Buy |
3,056
+142
| +5% | +$10.6K | 0.2% | 110 |
|
|
2018
Q4 | $213K | Buy |
+2,914
| New | +$206K | 0.25% | 89 |
|
Other funds holding MRK
VCM
VPM
MONECO Advisors's MRK Position: Q1 2026 in Review
MONECO Advisors increased its Merck (MRK) stake by 4.2% in Q1 2026, buying an estimated $60.7K and bringing the position to 13,015 shares worth $1.57M. The position accounts for 0.12% of the portfolio, ranked #162.
MONECO Advisors first reported a position in MRK in Q4 2018 and has held it in 30 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- MONECO Advisors held 13,015 shares of Merck worth $1.57M as of Q1 2026.
- MONECO Advisors bought 526 Merck shares in Q1 2026, an estimated $60.7K.
- Merck made up 0.12% of MONECO Advisors's portfolio in Q1 2026, its #162 holding.
- MONECO Advisors first reported a position in Merck in Q4 2018 and has held it in 30 quarters since.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on MONECO Advisors's 13F filing for Q1 2026, filed 8 May 2026.